210535-59-4Relevant academic research and scientific papers
Use of 4-substituted tetrahydropyridines for making medicines acting on TGF-β1
-
Page column 20-21, (2010/02/04)
The invention relates to the use of a compound of formula (I): for the preparation of pharmaceutical compositions for increasing the circulating, cellular and extracellular levels of TGF-β1.
Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination
-
, (2008/06/13)
The invention relates to the use of tetrahydropyridine derivatives of the formula in which: R1is a halogen or a CF3, (C1-C4)alkyl or (C1-C4)alkoxy group; Y is a nitrogen atom or a CH group;
Use of benzoylalkyl-1,2,3,6-tetrahydropyridines
-
, (2008/06/13)
The invention relates to the use of compounds of formula for the preparation of medicines designed for the treatment of neuronal and cerebral disorders. The invention also relates to the compounds of formula: a process for their preparation and the pharma
